Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19227010

Download in:

View as

General Info

PMID
19227010